-
Psyched: Compass Launches Center Of Excellence, Entheon Purchases HaluGen, Atai Buys Majority Stake In Recognify
Saturday, January 16, 2021 - 10:38am | 999Read More...Compass Launches Center Of Excellence Compass Pathways (NASDAQ: CMPS) officially launched the Centre of Excellence, in collaboration with The Sheppard Pratt Institute for Advanced Diagnostics and Therapeutics in Baltimore, Maryland. This “clinic model” will study and...
-
Entheon Acquires Pre-Testing Genetics Platform For Psychedelic Treatment
Thursday, January 14, 2021 - 4:35pm | 245Read More...Psychedelics biotech company Entheon Biomedical Corp. (CSE: ENBI) has purchased biotech company HaluGen Life Sciences Inc. in an all-stock transaction. Entheon acquired 100% of HaluGen in exchange for 5.1 million Entheon shares. Why Genetic Testing Is Important: Psychedelic compounds...
